Effect of contrast agent on the results of <i>in vivo</i><sup>1</sup>H MRS of breast tumors – is it clinically significant?
Pascal Baltzer(Medical University of Vienna), Werner A. Kaiser(Friedrich Schiller University Jena), Jürgen R. Reichenbach(Jena University Hospital), Alexander Gussew(University Hospital in Halle), Oumar Camara(Friedrich Schiller University Jena), R. Rzanny(Friedrich Schiller University Jena), Matthias Dietzel(Friedrich-Alexander-Universität Erlangen-Nürnberg), Mieczysław Gajda(Friedrich Schiller University Jena)
Cited by 22
Related Papers
METhodological RadiomICs Score (METRICS): a quality scoring tool for radiomics research endorsed by EuSoMII
|Insights into Imaging|2024|286
Impact of Machine Learning With Multiparametric Magnetic Resonance Imaging of the Breast for Early Prediction of Response to Neoadjuvant Chemotherapy and Survival Outcomes in Breast Cancer Patients
|Investigative Radiology|2018|278
Second International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions)
|Breast Cancer Research and Treatment|2018|251
MR venography of multiple sclerosis.
|PubMed|2000|202
False-Positive Findings at Contrast-Enhanced Breast MRI: A BI-RADS Descriptor Study
|American Journal of Roentgenology|2010|197